• 1
    Louis DN,Scheithauer BW,Budka H,von Deimling A,Kepes JJ. Meningiomas. In: KleihuesP,CaveneeWP, eds. WHO classification of tumours: tumours of the nervous system. Lyon: IARC Press, 2000; 17689.
  • 2
    İldan F,Tuna M,Göçer AI,Boyar B,Bağdatoğlu H,Şen O,Haciyakupoğlu S,Burgut R. Correlation of the relationships of brain-tumor interfaces, magnetic resonance imaging, and angiographic findings to predict cleavage of meningiomas. J Neurosurg 1999; 91: 38490.
  • 3
    Mantle RE,Lach B,Delgado MR,Baeesa S,Bélanger G. Predicting the probability of meningioma recurrence based on the quantity of peritumoral brain edema on computerized tomography scanning. J Neurosurg 1999; 91: 37586.
  • 4
    Niedermayer I,Kolles H,Zang KD,Feiden W. Characterization of intermediate type (WHO “atypical”) meningiomas. Clin Neuropathol 1996; 15: 3306.
  • 5
    Jellinger K,Slowik. Histological subtypes and prognostic problems in meningioma. J Neurol 1975; 208: 27998.
  • 6
    Jellinger K. Histopathological features predicting recurrence of meningiomas after (sub)total resection. Clin Neuropathol 1988; 7: 174.
  • 7
    McLean CA,Jolley D,Cukier E,Giles G,Gonzales MF. Atypical and malignant meningiomas: importance of micronecrosis as a prognostic indicator. Histopathology 1993; 23: 34953.
  • 8
    Takeuchi H,Kubota T,Kabuto M,Kitai R,Nozaki J,Yamashita J. Prediction of recurrence in histologically benign meningiomas: proliferating cell nuclear antigen and Ki-67 immunohistochemical study. Surg Neurol 1997; 48: 5016.
  • 9
    Zang KD,Singer H. Chromosomal constitution of meningiomas. Nature 1967; 216: 845.
  • 10
    Zankl H,Zang KD. Correlation between clinical and cytogenetical data in 180 human meningiomas. Cancer Genet Cytogenet 1980; 1: 3516.
  • 11
    Perry A,Gutmann DH,Reifenberger G. Molecular pathogenesis of meningiomas. J Neurooncol 2004; 70: 183302.
  • 12
    Bello MJ,de Campos JM,Kusak ME,Vaquero J,Sarasa JL,Pestana A,Rey JA. Allelic loss of 1p is associated with tumor progression of meningiomas. Genes Chromosomes Cancer 1994; 9: 2968.
  • 13
    Henn W,Cremerius U,Heide G,Lippitz B,Schröder JM,Gilsbach JM,Büll U,Zang KD. Monosomy 1p is correlated with enhanced in vivo glucose metabolism in meningiomas. Cancer Genet Cytogenet 1995; 79: 1448.
  • 14
    Kolles H,Niedermayer I,Schmitt Ch,Henn W,Feld R,Steudel WI,Zang KD,Feiden W. Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. Acta Neurochir (Vienna) 1995; 137: 17481.
  • 15
    Mueller P,Henn W,Niedermayer I,Ketter R,Feiden W,Steudel WI,Zang KD,Steilen-Gimbel. Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas. Clin Can Res 1999; 5: 356977.
  • 16
    Niedermayer I,Feiden W,Henn W,Steilen-Gimbel H,Steudel WI,Zang KD. Loss of alkaline phosphatase activity in meningiomas: a rapid histochemical technique indicating progression-associated deletion of a putative tumor suppressor gene on the distal part of the short arm of chromosome 1. J Neuropathol Exp Neurol 1997; 56: 87986.
  • 17
    Simon M,von Deimling A,Larson JJ,Wellenreuther R,Kaskel P,Waha A,Warnick RE,Tew JM,Jr,Menon AG. Allelic loss on chromosomes 14, 10 and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res 1995; 55: 4696701.
  • 18
    Ketter R,Henn W,Niedermayer I,Steilen-Gimbel H,König J,Zang KD,Steudel WI. Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: a retrospective study of 198 cases. J Neurosurg 2001; 95: 6017.
  • 19
    Zang KD. Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Cell Genet 2001; 93: 20720.
  • 20
    Weber RG,Boström J,Wolters M,Baudis M,Collins P,Reifenberger G,Lichter P. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: Toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 1997; 94: 1471924.
  • 21
    Steudel WI,Feld R,Henn W,Zang KD. Correlation between cytogenetic and clinical findings in 215 human meningiomas. Acta Neurochir[ Suppl] 1996; 65: 736.
  • 22
    Jiang F,Desper R,Papadimitriou CH,Schaffer AA,Kallioniemi OP,Richter J,Schraml P,Sauter G,Mihatsch MJ,Moch H. Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data. Cancer Res 2000; 60: 65039.
  • 23
    Beerenwinkel N,Rahnenführer J,Daumer M,Hoffmann D,Kaiser R,Selbig J,Lengauer T. Learning multiple evolutionary pathways from cross-sectional data. J Comput Biol 2005a; 12: 58498.
  • 24
    Desper R,Jiang F,Kallioniemi OP,Moch H,Papadimitriou CH,Schäffer AA. Inferring tree models for oncogenesis from comparative genome hybridization data. J Comput Biol 1999; 6: 3751.
  • 25
    von Heydebreck A,Gunawan B,Fuzesi L. Maximum likelihood estimation of oncogenetic tree models. Biostatistics 2004; 5: 54556.
  • 26
    Cox DR. Regression models and life tables (with Discussion). J R Stat Soc Ser B 1972; 34: 1874.
  • 27
    Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957; 20: 2239.
  • 28
    Limon J,Dal-Cin P,Sandberg AA. Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet 1986; 23: 30513.
  • 29
    Beerenwinkel N,Rahnenführer J,Kaiser R,Hoffmann D,Selbig J,Lengauer T. Mtreemix: a software package for learning and use mixture models of mutagenetic trees. Bioinformatics 2005b; 21: 21067.
  • 30
    Rahnenführer R,Beerenwinkel N,Schulz WA,Hartmann C,von Deimling A,Wullich B,Lengauer T. Estimating cancer survival and clinical outcome based on genetic tumor progession scores. Bioinformatics 2005; 21: 243846.
  • 31
    Chan RC,Thompson GB. Morbidity, mortality, and quality of life following surgery for intracranial meningiomas. A retrospective study in 257 cases. J Neurosurg 1984; 60: 5260.
  • 32
    Zülch KJ. Histological classification of tumors of the central nervous system, in International Histological Classification of Tumours No. 21. Geneva: World Health Organization, 1979, pp 4760.
  • 33
    Adegbite AB,Khan MI,Paine KWE,Tan LK. The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 1983; 58: 516.
  • 34
    Mirimanoff RO,Dosoretz DE,Linggood RM,Ojemann RG,Martuza RL. Meningioma. analysis of recurrence and progression following neurosurgical resection. J Neurosurg 1985; 62: 1824.
  • 35
    Scheithauer BW. Tumors of the meninges: proposed modifications of the World Health Organisation classification. Acta Neuropathol 1990; 80: 34354.
  • 36
    Cushing H. The cranial hyperostoses producted by meningeal endotheliomas. Arch Neurol Psychiat 1922; 8: 13952.
  • 37
    McCarthy BJ,Davis FG,Freels S,Surawicz TS,Damek DM,Grutsch J,Meneck HR,Lawser JR. Factors associated with survival in patients with meningioma. J Neurosurg 1998; 88: 8319.
  • 38
    Mahmood A,Caccamo DV,Tomecek FJ,Malik GM. Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery 1993; 33: 95563.
  • 39
    Perry A,Jenkins RB,Dahl RJ,Moertel CA,Scheithauer BW. Cytogenetic analysis of aggressive meningiomas. Cancer 1996; 77: 256773.
  • 40
    Maíllo A,Orfao A,Sayagués JM,Diaz P,Gomez-Moreta JA,Caballero M,Santamarta D,Santos-Briz A,Morales F,Tabernero MD. New classification scheme for the prognostic stratification of meningioma on the basis of chromosome 14 abnormalities, patient age, and tumor histopathology. J Clin Oncol 2003; 21: 328595.
  • 41
    Sayagués JM,Tabernero MD,Maíllo A,Espinosa A,Rasillo A,Díaz P,Ciudad J,López A,Merino M,Goncalves JM,Santos-Briz A,Morales F et al. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH). J Mol Diagn 2004; 6: 31625.
  • 42
    Menon GM,Rutter JL,von Sattel JP,Synder H,Murdoch C,Blumenfeld A,Martuza RL,von Deimling A,Gusella JF,Houseal TW. Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative “tumor progression” locus. Oncogene 1997; 14: 61116.
  • 43
    Espinosa AB,Tabernero MD,Maillo A,Sayagues JM,Ciudad J,Merino M,Alguero MC,Lubombo AM,Sousa P,Santos-Briz A,Orfao A. The cytogenetic relationship between primari and recurrent meningiomas points to the need for new treatment strategies in cases at high risk of relapse. Clin Cancer Res 2006; 12: 77280.
  • 44
    Zang KD. Cytological and cytogenetical studies on human meningioma. Cancer Genet Cytogenet 1982; 6: 24974.